JPS63196281A - Substrate for cell culture - Google Patents
Substrate for cell cultureInfo
- Publication number
- JPS63196281A JPS63196281A JP3048587A JP3048587A JPS63196281A JP S63196281 A JPS63196281 A JP S63196281A JP 3048587 A JP3048587 A JP 3048587A JP 3048587 A JP3048587 A JP 3048587A JP S63196281 A JPS63196281 A JP S63196281A
- Authority
- JP
- Japan
- Prior art keywords
- cell culture
- composite
- substrate
- cells
- inorganic material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004113 cell culture Methods 0.000 title claims abstract description 43
- 239000000758 substrate Substances 0.000 title claims abstract description 39
- 239000000463 material Substances 0.000 claims abstract description 29
- 229910010272 inorganic material Inorganic materials 0.000 claims abstract description 28
- 239000011147 inorganic material Substances 0.000 claims abstract description 28
- 239000002131 composite material Substances 0.000 claims abstract description 23
- 239000012510 hollow fiber Substances 0.000 claims abstract description 15
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 12
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 12
- 235000000346 sugar Nutrition 0.000 claims abstract description 11
- 150000002632 lipids Chemical class 0.000 claims abstract description 10
- 150000008163 sugars Chemical class 0.000 claims abstract description 9
- 150000001875 compounds Chemical class 0.000 claims abstract description 7
- 239000002861 polymer material Substances 0.000 claims description 10
- -1 tube Substances 0.000 abstract description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract description 5
- 239000011148 porous material Substances 0.000 abstract description 5
- 229910052588 hydroxylapatite Inorganic materials 0.000 abstract description 4
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 abstract description 4
- 229920000642 polymer Polymers 0.000 abstract description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 abstract description 3
- 229920001225 polyester resin Polymers 0.000 abstract description 2
- 239000004645 polyester resin Substances 0.000 abstract description 2
- 239000000377 silicon dioxide Substances 0.000 abstract description 2
- 235000012239 silicon dioxide Nutrition 0.000 abstract description 2
- 238000010030 laminating Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 46
- 108090000288 Glycoproteins Proteins 0.000 description 23
- 102000003886 Glycoproteins Human genes 0.000 description 23
- 239000000243 solution Substances 0.000 description 9
- 239000010408 film Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 230000035755 proliferation Effects 0.000 description 8
- 210000004102 animal cell Anatomy 0.000 description 6
- 238000012258 culturing Methods 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 3
- 230000021164 cell adhesion Effects 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000004417 polycarbonate Substances 0.000 description 3
- 229920000515 polycarbonate Polymers 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 230000007480 spreading Effects 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000699802 Cricetulus griseus Species 0.000 description 2
- 108010067306 Fibronectins Proteins 0.000 description 2
- 102000016359 Fibronectins Human genes 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 229930186217 Glycolipid Natural products 0.000 description 2
- 239000000232 Lipid Bilayer Substances 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000004544 sputter deposition Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 239000004709 Chlorinated polyethylene Substances 0.000 description 1
- 208000030275 Chondronectin Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108010022355 Fibroins Proteins 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 108010085895 Laminin Proteins 0.000 description 1
- 102000007547 Laminin Human genes 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 108010031318 Vitronectin Proteins 0.000 description 1
- 102100035140 Vitronectin Human genes 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000012461 cellulose resin Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000011243 crosslinked material Substances 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 150000002298 globosides Chemical class 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- 108700020610 human chondronectin Proteins 0.000 description 1
- 102000043667 human chondronectin Human genes 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 229920000554 ionomer Polymers 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001230 polyarylate Polymers 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920006380 polyphenylene oxide Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000007738 vacuum evaporation Methods 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
〈産業上の利用分野〉
この発明は、細胞培養用基材に関する。さらに詳細には
、動物細胞を培養するために使用される細胞培養用基材
に関するものである。DETAILED DESCRIPTION OF THE INVENTION <Industrial Application Field> The present invention relates to a substrate for cell culture. More specifically, the present invention relates to a cell culture substrate used for culturing animal cells.
〈従来技術及び発明が解決しようとする問題点〉近年、
生物の細胞を培養し、その細胞の代謝活動により有用な
生理活性物質、例えば、ワクチン、ホルモン、インター
フェロン等を生産する研究が活発に行われている。<Prior art and problems to be solved by the invention> In recent years,
BACKGROUND OF THE INVENTION Research is actively being carried out to cultivate biological cells and produce useful physiologically active substances, such as vaccines, hormones, and interferons, through the metabolic activities of the cells.
このような方法において、従来、接着性動物細胞の培養
は、ガラス、プラスチック製のシャーレ、試験管、培養
ビンなどを用いて行なわれてきた。In such methods, adherent animal cells have conventionally been cultured using glass or plastic petri dishes, test tubes, culture bottles, and the like.
また、最近、マイクロキャリアや中空糸を培養用基材と
して用い、より高密度の培養や、長期の培養を行なう試
みがなされつつある。接着性動物細胞を培養周基村上に
接着させ、増殖させるには、基材表面と細胞の接着性が
良好であることと共に接着した細胞の形態、配列が、細
胞の伸展、増殖に有効な形態となっていることが必要で
ある。しかしながら、従来から細胞培養用基材として用
いられている高分子材料は賦形性、耐久性に優れるもの
の、上記接着性等の点に関して不適当であり、高密度か
つ長期間の細胞培養を行なうことができず、いずれも十
分な成果を上げるに至っていない。Recently, attempts have been made to use microcarriers and hollow fibers as culture substrates to achieve higher-density culture and longer-term culture. In order to adhere and proliferate adherent animal cells on a cultured substrate, it is necessary to have good adhesion between the cells and the substrate surface, as well as the form and arrangement of the adhered cells in a form that is effective for cell expansion and proliferation. It is necessary that the However, although the polymer materials conventionally used as substrates for cell culture have excellent shapeability and durability, they are unsuitable in terms of adhesive properties, etc., and cannot be used for high-density and long-term cell culture. However, none of them have been able to achieve sufficient results.
この一点を改善するため、生体高分子であるコラーゲン
やその変性物であるゼラチンを高分子材料上に塗布した
もの(特開昭58−71884号公報参照)や、高分子
材料上に可溶性フィブロインの架橋体が積層された細胞
培養床(特開昭81−52280号公報参照)が提案さ
れている。In order to improve this point, we have developed a method in which collagen, which is a biopolymer, or gelatin, which is a modified product of collagen, is coated on a polymer material (see JP-A-58-71884), and a method in which soluble fibroin is coated on a polymer material. A cell culture bed in which crosslinked materials are laminated (see Japanese Patent Application Laid-Open No. 81-52280) has been proposed.
しかしながら、上記の従来技術は、高分子基材への糖や
蛋白質などの固定化が十分でなく容易に脱離してしまい
、細胞の接着性並びに接着した細胞の伸展性、増殖性お
よび活性維持が未だ十分でなく、高密度、長期間の細胞
培養ができないという問題点がある。However, in the above-mentioned conventional technology, sugars and proteins are not sufficiently immobilized on the polymeric substrate and easily detach, resulting in poor cell adhesion, as well as the spreadability, proliferation, and activity maintenance of adhered cells. There is still a problem that it is not sufficient and high-density, long-term cell culture is not possible.
く目 的〉
この発明は上記問題点に鑑みてなされたものであり、細
胞の接着性、伸展および増殖に優れ、高密度かつ長期間
の細胞培養を可能ならしめる細胞培養用基材を提供する
ことを目的とする。Purpose This invention was made in view of the above problems, and provides a cell culture substrate that has excellent cell adhesion, spreading, and proliferation, and enables high-density and long-term cell culture. The purpose is to
く問題点を解決するための手段および作用〉上記目的を
達成するためになされた、この発明の細胞培養用基材は
、高分子材料と無機材料とからなる複合体の表面上に、
糖、蛋白質、脂質およびそれらの複合化合物(以下、こ
れらを糖蛋白質等と称する)が担持されていることを特
徴とするものである。Means and Effects for Solving the Problems> The cell culture substrate of the present invention, which has been made to achieve the above object, has the following features:
It is characterized by supporting sugars, proteins, lipids, and complex compounds thereof (hereinafter referred to as glycoproteins, etc.).
なお、上記複合体は、高分子材料に無機材料が充填され
たものでも、高分子材料上に無機材料が積層されたもの
でもよい。また複合体は、多孔性であるものが好ましく
、中空糸形状であるものがさらに好ましい。さらに、複
合体の表面に糖蛋白質等が部分的に担持されているもの
、特に、格子模様、縞模様、水玉模様等に糖蛋白質等が
担持されているものが好ましい。Note that the above-mentioned composite may be one in which a polymer material is filled with an inorganic material, or one in which an inorganic material is laminated on a polymer material. Further, the composite is preferably porous, and more preferably has a hollow fiber shape. Further, it is preferable to use a complex in which glycoprotein or the like is partially supported on the surface of the complex, particularly one in which glycoprotein or the like is supported in a checkered pattern, a striped pattern, a polka dot pattern, or the like.
上記のように、この発明は高分子材料と無機材料との複
合体を用いており、無機材料は親水性に富み、糖蛋白質
等との親和性が高く、基材に糖蛋白質等を安定かつ強固
に固定化することができる。As mentioned above, this invention uses a composite of a polymeric material and an inorganic material, and the inorganic material is highly hydrophilic and has a high affinity for glycoproteins, etc. Can be firmly immobilized.
さらに、該複合体上に担持される糖蛋白質等は、細胞と
の接着性に優れ、細胞が安定した形態、配置で接着する
ことができる。すなわち、細胞表面の細胞膜の構造は、
脂質二重層の中に、膜内粒子と呼ばれる各種の糖蛋白質
、糖脂質等が分布をもって埋めこまれており、これらが
、上記脂質二重層の中を自由に移動でき細胞の接着に関
与している。上記糖蛋白質等は、膜内粒子と共有結合、
イオン結合、疎水結合等により結合可能な部位を有する
ので、細胞との接着性が高まると共に細胞を安定した形
態、配置で保持することができる。従って、本発明の細
胞培養用基材は、細胞の安定な接着を促すと共に接着し
た細胞の良好な伸展および増殖を可能にすることができ
る。Furthermore, the glycoprotein etc. supported on the complex has excellent adhesion to cells, and allows cells to adhere in a stable form and arrangement. In other words, the structure of the cell membrane on the cell surface is
Various glycoproteins, glycolipids, etc. called intramembrane particles are embedded in the lipid bilayer in a distributed manner, and these can move freely within the lipid bilayer and are involved in cell adhesion. There is. The above glycoproteins etc. are covalently bonded to intramembrane particles,
Since it has a site that can be bonded by ionic bond, hydrophobic bond, etc., adhesiveness with cells is increased and cells can be held in a stable form and arrangement. Therefore, the cell culture substrate of the present invention can promote stable adhesion of cells and enable good spread and proliferation of adhered cells.
また、上記高分子材料が、多孔質材料であるときは、多
孔質材料の孔を通じて物質代謝が容易となり長期に亘り
細胞培養することができる。特に、前記高分子材料から
なる基材が中空糸であるものは、中空部内や中空糸の外
側に培養液等を泡流することにより、中空糸上に細胞を
高密度に育成、増殖させることができる。Further, when the polymeric material is a porous material, substance metabolism is facilitated through the pores of the porous material, and cells can be cultured for a long period of time. In particular, when the base material made of the polymeric material is a hollow fiber, cells can be grown and multiplied at high density on the hollow fiber by flowing a culture solution or the like into the hollow part or outside the hollow fiber. Can be done.
さらに、複合体の表面に糖蛋白質等が部分的に担持され
ているもの、特に、格子模様、縞模様、水玉模様等に糖
蛋白質等が担持されているものは、接着する細胞の位置
を調整でき、細胞が所定の間隔をもって接着するので、
細胞との接着がさらに安定化し、細胞の伸展、増殖をよ
り一層増大させることができる。Furthermore, when glycoproteins, etc. are partially supported on the surface of the complex, especially when glycoproteins, etc. are supported in a checkered pattern, striped pattern, polka dot pattern, etc., the position of the adhering cells is adjusted. Because the cells adhere to each other at regular intervals,
Adhesion with cells is further stabilized, and cell spreading and proliferation can be further increased.
以下、この発明をより詳細に説明する。This invention will be explained in more detail below.
この発明の細胞培養用基材は、高分子材料と無機材料と
からなる複合体の表面上に、糖蛋白質等のいずれか1種
類以上が担持された構造を存する。The cell culture substrate of the present invention has a structure in which one or more types of glycoproteins and the like are supported on the surface of a composite made of a polymeric material and an inorganic material.
上記高分子材料としては、賦形性、機械的強度を有する
ものであればいかなるものでも使用でき、例えば、ポリ
エチレン、ポリプロピレン、塩素化ポリエチレン、アイ
オノマー等のオレフィン系重合体、ポリテトラフルオロ
エチレン、ポリフッ化ビニリデン等のフッ素系樹脂、ポ
リスチレン等のスチレン系樹脂、ポリメチルメタクリレ
ート等のアクリル系樹脂、ポリビニルアルコール、ポリ
酢酸ビニル、ポリビニルアセタール、ポリアクリロニト
リル、ポリ塩化ビニル、ポリ塩化ビニリデン、ポリカー
ボネート、ボリアリレート、ポリフェニレンオキサイド
、ポリエチレンテレフタレート、ポリブチレンテレフタ
レート等のポリエステル樹脂、エポキシ樹脂、ポリアミ
ド、ポリイミド、ポリスルホン、セルロース系樹脂、シ
リコーン樹脂、ポリウレタンなどの種々の重合体もしく
は共重合体またはそれらのブレンド物が例示できる。As the above-mentioned polymeric material, any material can be used as long as it has formability and mechanical strength. For example, olefinic polymers such as polyethylene, polypropylene, chlorinated polyethylene, and ionomers, polytetrafluoroethylene, and Fluorine resins such as vinylidene chloride, styrene resins such as polystyrene, acrylic resins such as polymethyl methacrylate, polyvinyl alcohol, polyvinyl acetate, polyvinyl acetal, polyacrylonitrile, polyvinyl chloride, polyvinylidene chloride, polycarbonate, polyarylate, Examples include various polymers or copolymers, or blends thereof, such as polyester resins such as polyphenylene oxide, polyethylene terephthalate, and polybutylene terephthalate, epoxy resins, polyamides, polyimides, polysulfones, cellulose resins, silicone resins, and polyurethanes.
無機材料としては、種々の無機物質が使用できるが、特
に、アルミナ、二酸化ケイ素、シリカゲル、水酸アパタ
イト[Cac (POa )s (OH)2] 、リン
酸三カルシウムおよび下記の組成からなるガラス
Na 20− Ca 0−St o、 −p2o s
、Me 0−Ca 0−8L Ot −ho s
、hh 20−KzO−F’a 0−Ca o−st
Ot −PtO5、等は生体親和性もよ(好適に利用
される。Various inorganic substances can be used as the inorganic material, but in particular, alumina, silicon dioxide, silica gel, hydroxyapatite [Cac(POa)s(OH)2], tricalcium phosphate, and glass Na having the following composition. 20-Ca0-Sto, -p2os
, Me 0-Ca 0-8L Ot -ho s
, hh 20-KzO-F'a 0-Ca o-st
Ot-PtO5, etc. have good biocompatibility (they are preferably used).
上記の高分子材料と無機材料との複合体は、慣用の方法
でへ造することができる。例えば、無機材料の微粉末を
高分子材料に分散させ成形することにより、高分子材料
に無機材料が充填形態の複合体が得られる。この方法に
よれば、賦形性に富む高分子材料中に無機材料が充填さ
れているので、無機材料の賦形性に劣り、中空糸状や、
物質透過性の高い多孔性成形品を得ることが困難である
という欠点を補い、種々の形状の基材とすることができ
るという利点がある。The composite of the above-mentioned polymeric material and inorganic material can be produced by a conventional method. For example, by dispersing fine powder of an inorganic material in a polymeric material and molding it, a composite in which the polymeric material is filled with the inorganic material can be obtained. According to this method, since the inorganic material is filled in a polymeric material with high shapeability, the shapeability of the inorganic material is poor, and the
It compensates for the drawback that it is difficult to obtain porous molded products with high substance permeability, and has the advantage that it can be used as a base material of various shapes.
また、所定の形状に成形された高分子材料に、無機材料
の微粉末をバインダーに分散させた分散液を塗布し乾燥
したり、または真空蒸着、イオンブレーティング、スパ
ッタリング等のドライプロセスを用いて、無機材料を蒸
着させることなどにより、高分子材料上に無機材料が積
層された形態の複合体が得られる。この場合、無機材料
は必ずしも高分子材料の全面を覆う必要はなく、高分子
材料表面に点在していてもよい。なお、この積層法でも
、予め所望形状に成形された高分子材料に積層されるの
で、種々の形状の細胞培養用基材を得ることができる。In addition, a dispersion of fine powder of inorganic material dispersed in a binder is applied to a polymer material molded into a predetermined shape and dried, or a dry process such as vacuum evaporation, ion blating, or sputtering is used. By evaporating an inorganic material or the like, a composite in the form of an inorganic material layered on a polymeric material can be obtained. In this case, the inorganic material does not necessarily need to cover the entire surface of the polymeric material, and may be scattered on the surface of the polymeric material. Note that in this lamination method as well, since the polymer material is laminated on a polymer material that has been formed into a desired shape in advance, cell culture substrates of various shapes can be obtained.
上記の高分子材料と無機材料の使用比率は、高分子材料
や無機材料の種類、複合体の形態等により適宜変更され
るが、例えば、無機材料が高分子材料に充填された形態
にあっては、無機材料は5〜80重量%、好ましくは2
0〜60重量%程度添加される。また、高分子材料上に
無機材料が積層された形態の複合体にあっては、無機材
料薄膜を0.01〜10M、好ましくは0.05〜0゜
57711程度積層する。The usage ratio of the above polymeric material and inorganic material may be changed depending on the type of polymeric material or inorganic material, the form of the composite, etc., but for example, if the inorganic material is in the form of a polymeric material filled The inorganic material is 5 to 80% by weight, preferably 2
It is added in an amount of about 0 to 60% by weight. Further, in the case of a composite in which an inorganic material is laminated on a polymeric material, the inorganic material thin film is laminated at an angle of 0.01 to 10M, preferably 0.05 to 0.57711.
この発明の細胞培養用基材は、上記の複合体の表面上に
糖蛋白質等を担持させることにより得られる。ここで用
いる糖蛋白質等は、細胞と親和性があり、基材と細胞の
接着を促進するものであればいずれも用いることができ
、例えば、ラクトース、ガラクトース等のオリゴ糖、ア
ルブミン等の蛋白質、リン脂質等の脂質、グロボシド、
ガングリオシド等の糖と脂質との複合体である糖脂質、
細胞質や血清中に含まれる脂質と蛋白質との複合体であ
るリボ蛋白質、糖と蛋白質との複合体である糖蛋白質等
が挙げられ、特にオリゴ糖、コラーゲン、ゼラチン、フ
ィブロネクチン、ラミニン、コンドロネクチン、ビトロ
ネクチン、フィブリン等の糖蛋白質が好適に用いられ、
これらは2種またはそれ以上組み合せて使用することも
有用である。複合体上に糖蛋白質等を担持する方法は、
従来の技術がいずれも応用できる。一般には、所定形状
に成形された複合体を、上記の糖蛋白質等の1種類また
は2種類以上を自存する溶液に浸漬したり、該溶液を複
合体上に塗布した後、乾燥することにより行われる。こ
の際、糖蛋白質等が変性しにくい条件で乾燥するのが好
ましい。The cell culture substrate of the present invention can be obtained by supporting a glycoprotein or the like on the surface of the above-described composite. The glycoproteins used here can be any as long as they have an affinity for cells and promote adhesion between the substrate and cells, such as oligosaccharides such as lactose and galactose, proteins such as albumin, Lipids such as phospholipids, globosides,
Glycolipids, which are complexes of sugars such as gangliosides and lipids,
These include riboproteins, which are complexes of lipids and proteins contained in cytoplasm and serum, and glycoproteins, which are complexes of sugars and proteins, and in particular, oligosaccharides, collagen, gelatin, fibronectin, laminin, chondronectin, Glycoproteins such as vitronectin and fibrin are preferably used,
It is also useful to use two or more of these in combination. The method of supporting glycoprotein etc. on the complex is as follows.
All conventional techniques can be applied. Generally, this is carried out by immersing a complex formed into a predetermined shape in a solution containing one or more of the above-mentioned glycoproteins, or by applying the solution onto the complex and then drying it. be exposed. At this time, it is preferable to dry under conditions that do not easily denature glycoproteins and the like.
上記糖蛋白質等の担持は、単分子層、多分子層のいずれ
でもよく、また複合体表面の全面に積層してもよいが、
複合体表面に部分的に、特にパターン化して担持したも
のが好ましく、このようにパターン化して担持すること
により、複合体上に接着する細胞の配置を制御でき、ひ
いては細胞の接着性が安定化し、細胞の伸展、増殖およ
び機能発現を有利にすることができる。さらに、糖蛋白
質等を上記のように部分的に担持する場合、特に、格子
状、縞模様、水玉模様等の微細模様に担持することによ
り、上記効果をさらに増進できる有用な表面を形成する
ことができる。複合体上に糖蛋白質等をパターン化して
担持するには、例えば、スクリーン印刷等の技術を応用
して行なうことができる。The above-mentioned glycoprotein, etc. may be supported in either a monomolecular layer or a multimolecular layer, or may be laminated on the entire surface of the complex, but
Preferably, it is supported partially on the surface of the complex, particularly in a patterned manner. By supporting it in a patterned manner, the arrangement of cells adhering to the complex can be controlled, and the adhesion of the cells can be stabilized. , can favor cell spreading, proliferation and functional expression. Furthermore, when glycoproteins and the like are partially supported as described above, a useful surface that can further enhance the above effects can be formed by supporting them in a fine pattern such as a lattice pattern, a striped pattern, a polka dot pattern, etc. Can be done. In order to support glycoproteins and the like on the complex in a patterned manner, techniques such as screen printing can be applied, for example.
この発明の細胞培養用基材は、種々の形態で用いること
ができ、例えば、シャーレ、フラスコ等の成形品の他、
フィルム、チューブ、中空糸、繊維、微粒子等の形態が
例示できる。これらの形態のうち、長期に亘り細胞培養
を行なうには、物質代謝を容易にする孔を有する多孔質
高分子材料が好ましく、また、高密度培養を行なうには
、チューブ、中空糸の形状が好適である。特に、物質代
謝が容易で、高密度培養を長期に亘り行なえる多孔質高
分子材料からなる中空糸が好ましい。この中空糸を用い
るとき、培養液を、中空糸の中空部または外側に潅流さ
せ、必要に応じて炭酸ガスや空気等を上記中空糸の中空
部等に送ることにより、細胞を中空糸上で育成し、増殖
させることができる。なお、前記中空糸としては、種々
の大きさのものが使用でき、例えば、内径50〜100
0μm程度のものが用いられる。The cell culture substrate of the present invention can be used in various forms, for example, in addition to molded products such as petri dishes and flasks,
Examples include forms such as films, tubes, hollow fibers, fibers, and fine particles. Among these forms, for long-term cell culture, porous polymeric materials with pores that facilitate material metabolism are preferable, and for high-density culture, tubes and hollow fibers are preferable. suitable. Particularly preferred are hollow fibers made of porous polymeric materials that are easy to metabolize and can be cultured at high density for a long period of time. When using this hollow fiber, cells are grown on the hollow fiber by perfusing the culture solution into the hollow part or outside of the hollow fiber, and by sending carbon dioxide gas, air, etc. into the hollow part of the hollow fiber as necessary. It can be cultivated and multiplied. Note that the hollow fibers can be of various sizes, for example, those with an inner diameter of 50 to 100
A material with a diameter of about 0 μm is used.
また、この発明の細胞培養用基材をマイクロキャリアー
法のビーズ担体として使用する場合には、100〜30
0声程度の粒径のものが用いられる。In addition, when using the cell culture substrate of the present invention as a bead carrier in the microcarrier method,
Particles with a particle size of about 0 tones are used.
この発明の細胞培養用基材は、種々の細胞の培養に使用
することができ、細胞の種類は特に限定されず生体由来
細胞、ハイブリドーマ−等が挙げられ、例えば、チャイ
ニーズハムスター肺由来細胞V−79、ヒト子宮癌由来
細胞HeLa、ヒト胎児肺由来細胞MRC−5、ヒト肝
由来細胞Chang Liver s ヒト肺由来正二
倍体線維芽細胞■RC−90、ヒトリンパ腫由来ナマル
バ細胞等が例示される。The cell culture substrate of the present invention can be used for culturing various cells, and the type of cells is not particularly limited, and examples include living body-derived cells, hybridomas, etc. For example, Chinese hamster lung-derived cells V- 79, human uterine cancer-derived cells HeLa, human fetal lung-derived cells MRC-5, human liver-derived cells Chang Livers, human lung-derived eudiploid fibroblasts ■RC-90, human lymphoma-derived Namalva cells, and the like.
また、この発明の細胞培養用基材を用いて動物°細胞を
培養する場合、培養する細胞の種類に応じて種々の培養
液が用いられ、細胞の増殖に適した至適温度、pH等の
条件で培養が行なわれる。In addition, when culturing animal cells using the cell culture substrate of the present invention, various culture media are used depending on the type of cells to be cultured, and the optimal temperature, pH, etc. suitable for cell proliferation are used. Cultivation is carried out under these conditions.
本発明の細胞培養用基材は、従来公知の種々のモジュー
ルにて、動物細胞の増殖に適用できる。The cell culture substrate of the present invention can be applied to the proliferation of animal cells in various conventionally known modules.
本発明の細胞培養基材としてフィルム状基材を用いたモ
ジュールの一例を、添付図面に基づいて説明すると以下
の通りである。An example of a module using a film-like substrate as a cell culture substrate of the present invention will be described below based on the accompanying drawings.
添付図面に示す細胞培養器は、サポートスクリーン(2
)上に載置されたフィルム状細胞培養用基材(1)の両
端が、ポリカーボネート等からなるハウジング口)内の
両側に設けられたスペーサ(6)により保持されている
。また、上記ハウジング(3)には、増殖させる細胞懸
濁液をハウジング(3)内に満すための孔(4)が設け
られていると共に、培養液を潅流させるための管(5)
が取付られている。なお、上記孔(4)は、細菌等が侵
入するのを防止するため、フィルタ付きの蓋ので被冠さ
れている。The cell culture vessel shown in the attached drawing is equipped with support screens (2
Both ends of the film-like cell culture substrate (1) placed on ) are held by spacers (6) provided on both sides within the housing opening made of polycarbonate or the like. Further, the housing (3) is provided with a hole (4) for filling the housing (3) with a cell suspension to be proliferated, and a tube (5) for perfusing the culture solution.
is installed. Note that the hole (4) is covered with a lid with a filter to prevent bacteria and the like from entering.
上記の細胞培養器を用いて細胞を増殖させるには、上記
孔(4)から細胞懸濁液を注入して細胞を前記基材(1
)上に接着させると共に、前記孔(4)をフィルタ付き
の上記蓋(7)で被冠し、所定の培養条件の下、上記培
養液を前記管(5)を通じて所定時間潅流させることに
より行なわれる。In order to proliferate cells using the cell culture device described above, a cell suspension is injected through the hole (4) and the cells are grown in the substrate (1).
), the hole (4) is covered with the lid (7) with a filter, and the culture solution is perfused through the tube (5) for a predetermined time under predetermined culture conditions. It will be done.
〈実施例〉
以下、実施例に基づいてこの発明をより詳細に説明する
。<Examples> Hereinafter, the present invention will be described in more detail based on examples.
実施例1および比較例
ポリプロピレンに水酸アパタイト(平均粒径1.2μm
)を重量比率40%で充填し、厚さ300μmのフィル
ムに成形した。このフィルムを45 mmφのガラスシ
ャーレにセットし、高圧蒸気滅菌後、無菌のフィブロネ
クチン(シグマ社製、牛血清より採取)のトリス緩衝溶
液(濃度0.1 ■/ 11 )を塗布し、室温で乾燥
させた。これらの操作は、全て無菌的に行なった。この
シャーレでチャイニーズハムスター肺由来細胞(V−7
9)を培養した。培養液として、10重量%牛脂児血清
を含むイーグルMEM培地を用いた。培養液111当り
I X 104個の培養細胞を播種し、5%炭酸ガス、
95%空気雰囲気、温度37℃の環境下、7日間の培養
を行なったところ、培養液111当り、平均6.1×1
06個の細胞数となり、良好な増殖が確認された。Example 1 and Comparative Examples Hydroxyapatite (average particle size 1.2 μm) was added to polypropylene.
) was filled at a weight ratio of 40% and formed into a film with a thickness of 300 μm. This film was set in a 45 mm diameter glass petri dish, and after sterilization using high-pressure steam, a Tris buffer solution (concentration 0.1/11) of sterile fibronectin (manufactured by Sigma, collected from bovine serum) was applied and dried at room temperature. I let it happen. All these operations were performed aseptically. In this petri dish, Chinese hamster lung-derived cells (V-7
9) was cultured. Eagle's MEM medium containing 10% by weight tallow serum was used as the culture solution. I x 104 cultured cells were seeded per 111 culture fluids, and 5% carbon dioxide gas was added.
When cultured for 7 days in a 95% air atmosphere and a temperature of 37°C, an average of 6.1 x 1
The number of cells was 0.06, confirming good proliferation.
一方、水酸アパタイトを充填していないポリプロピレン
フィルムを用いた他は、上記実施例1と同様に試験を行
なった比較例では、培養液111当り、平均8.4×1
05個の細胞数となった。On the other hand, in a comparative example in which the test was conducted in the same manner as in Example 1 except that a polypropylene film not filled with hydroxyapatite was used, an average of 8.4 × 1
The number of cells was 0.05.
実施例2
四弗化エチレン樹脂からなる多孔質フィルム(住人電気
工業(株)製、フロロボアFP−022)をスパッタリ
ング装置に置き、アルミナをターゲットとしてスパッタ
リング蒸着した。処理条件は、13.58 M Hzの
高周波電源を用い、窒素ガス中で、100 W、 5分
間の処理であった。次いで、この処理フィルムにメタル
スクリーンを用いて、コラーゲン(タイプI、濃度0.
3%)の処理幅40μm1非処理幅40坤の縞模様を形
成した後、乾燥させて、縞模様にコラーゲンを担持した
。細胞培養用基材としての上記複合フィルムを、添付図
面に示すポリカーボネート製細胞培養器(内径47 m
mφ)に装着し、全体をエチレンオキサイドガス滅菌し
た後、過剰の無菌水、培養液でフラッシングし、次いで
、孔(4)からヒト胎児包皮由来細胞(Flow 7
000)のイーグルM E M (1096牛脂児血清
添加)懸濁液(細胞数2X104個/厭)を満した。孔
(4)には、細菌をカットするフィルタ付きの蓋(7)
をし、管(5)を通して新鮮なイーグル培地を潅流し、
37℃で1週間培養を行なった。培養終了後、フィルム
に付着している細胞数を測定したところ、5.2×10
4個/ ylに増殖していることがわかった。Example 2 A porous film made of tetrafluoroethylene resin (Fluorobor FP-022, manufactured by Sumitomo Denki Kogyo Co., Ltd.) was placed in a sputtering apparatus, and alumina was sputter-deposited using a target. The processing conditions were 100 W for 5 minutes using a 13.58 MHz high frequency power source in nitrogen gas. Next, using a metal screen on this treated film, collagen (type I, concentration 0.
After forming a striped pattern with a treated width of 40 μm and an untreated width of 40 μm (3%), the striped pattern was dried to support collagen on the striped pattern. The above composite film as a cell culture substrate was used in a polycarbonate cell culture vessel (inner diameter 47 m) shown in the attached drawings.
mφ), the entire body was sterilized with ethylene oxide gas, flushed with excess sterile water and culture solution, and then human fetal foreskin-derived cells (Flow 7
000) Eagle MEM (1096 tallow serum supplemented) suspension (2 x 104 cells/cell) was filled. The hole (4) has a lid (7) with a filter to cut out bacteria.
and perfuse with fresh Eagle medium through tube (5).
Culture was performed at 37°C for one week. After culturing, the number of cells attached to the film was measured and found to be 5.2 x 10
It was found that the number of cells had grown to 4/yl.
〈発明の効果〉
以上のように、この発明の細胞培養用基材によれば、高
分子材料と親水性に富む無機材料との複合体の表面上に
糖蛋白質等が担持されているので、糖蛋白質等との接着
性に優れた基材が得られる。<Effects of the Invention> As described above, according to the cell culture substrate of the present invention, glycoproteins and the like are supported on the surface of the composite of a polymeric material and a highly hydrophilic inorganic material. A base material with excellent adhesion to glycoproteins etc. can be obtained.
さらに、糖蛋白質等は、細胞の親和性に優れ、接着性を
高めることができると共に細胞を伸展、増殖に適した形
態、配列で接着させることができるので、高密度かつ長
期間の細胞培養が可能になるという特有の効果を奏する
。従って、この発明の細胞培養用基材は、動物細胞の培
養によるホルモン等の有用物の生産システムに利用でき
る他、例えばインスリン産生細胞を複合体表面に接着、
培養することにより人工膵臓が形成できるように人工臓
器の構築に利用できる。Furthermore, glycoproteins have excellent affinity for cells and can increase adhesion, as well as allow cells to adhere in a form and arrangement suitable for expansion and proliferation, allowing for high-density and long-term cell culture. It has the unique effect of making it possible. Therefore, the cell culture substrate of the present invention can be used in a system for producing useful products such as hormones by culturing animal cells, and can also be used, for example, in adhering insulin-producing cells to the composite surface.
It can be used to construct artificial organs, such as the formation of an artificial pancreas by culturing.
図は、本発明の細胞培養用基材を用いた細胞培養器の一
例を示す断面図である。
(1)・・・細胞培養用基材、■・・・サポートスクリ
ーン、(3)・・・ハウジング、(4)・・・孔、(5
)・・・管。The figure is a sectional view showing an example of a cell culture device using the cell culture substrate of the present invention. (1)... Substrate for cell culture, ■... Support screen, (3)... Housing, (4)... Hole, (5
)···tube.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3048587A JPS63196281A (en) | 1987-02-12 | 1987-02-12 | Substrate for cell culture |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3048587A JPS63196281A (en) | 1987-02-12 | 1987-02-12 | Substrate for cell culture |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63196281A true JPS63196281A (en) | 1988-08-15 |
Family
ID=12305137
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3048587A Pending JPS63196281A (en) | 1987-02-12 | 1987-02-12 | Substrate for cell culture |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63196281A (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991016072A1 (en) * | 1990-04-16 | 1991-10-31 | President And Fellows Of Harvard College | Hydroxyapatite-antigen conjugates and methods for generating a poly-ig immune response |
GB2254085A (en) * | 1991-03-02 | 1992-09-30 | Mitsubishi Materials Corp | Carriers for culturing adhering cells |
US5162225A (en) * | 1989-03-17 | 1992-11-10 | The Dow Chemical Company | Growth of cells in hollow fibers in an agitated vessel |
WO1994016058A1 (en) * | 1992-12-31 | 1994-07-21 | Jess Paul Fuller | Cell support structures |
GB2289678A (en) * | 1992-12-31 | 1995-11-29 | Jess Paul Fuller | Cell support structures |
US6242247B1 (en) * | 1996-06-04 | 2001-06-05 | Sulzer Orthopedics Ltd. | Method for making cartilage and implants |
WO2007097273A1 (en) * | 2006-02-24 | 2007-08-30 | Kuraray Co., Ltd. | Cell culture container made of resin and method of producing the same |
WO2007105418A1 (en) * | 2006-02-24 | 2007-09-20 | Kuraray Co., Ltd. | Cell culture container and method of producing the same |
KR100842378B1 (en) * | 2007-04-27 | 2008-07-01 | 양현진 | Scaffolds increased specific gravity for cell culture and method for manufacturing thereof |
JP2011125232A (en) * | 2009-12-15 | 2011-06-30 | Hoya Corp | Cell culture carrier, and method for producing the same |
WO2017051912A1 (en) * | 2015-09-25 | 2017-03-30 | 三菱瓦斯化学株式会社 | Substrate for cell culture, cell culture method using same, cell culture vessel, and use as substrate |
-
1987
- 1987-02-12 JP JP3048587A patent/JPS63196281A/en active Pending
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5162225A (en) * | 1989-03-17 | 1992-11-10 | The Dow Chemical Company | Growth of cells in hollow fibers in an agitated vessel |
WO1991016072A1 (en) * | 1990-04-16 | 1991-10-31 | President And Fellows Of Harvard College | Hydroxyapatite-antigen conjugates and methods for generating a poly-ig immune response |
US5443832A (en) * | 1990-04-16 | 1995-08-22 | Institut Swisse De Recherches Experimentales Sur Le Cancer | Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response |
GB2254085A (en) * | 1991-03-02 | 1992-09-30 | Mitsubishi Materials Corp | Carriers for culturing adhering cells |
GB2254085B (en) * | 1991-03-02 | 1995-05-31 | Mitsubishi Materials Corp | Cell culturing in serum-free media |
WO1994016058A1 (en) * | 1992-12-31 | 1994-07-21 | Jess Paul Fuller | Cell support structures |
GB2289678A (en) * | 1992-12-31 | 1995-11-29 | Jess Paul Fuller | Cell support structures |
GB2289678B (en) * | 1992-12-31 | 1996-11-27 | Jess Paul Fuller | Silicone rubber cell support structures |
US6242247B1 (en) * | 1996-06-04 | 2001-06-05 | Sulzer Orthopedics Ltd. | Method for making cartilage and implants |
US6387693B2 (en) | 1996-06-04 | 2002-05-14 | Sulzer Orthopedics Ltd. | Method for producing cartilage tissue and implants for repairing enchondral and osteochondral defects as well as arrangement for carrying out the method |
WO2007097273A1 (en) * | 2006-02-24 | 2007-08-30 | Kuraray Co., Ltd. | Cell culture container made of resin and method of producing the same |
WO2007105418A1 (en) * | 2006-02-24 | 2007-09-20 | Kuraray Co., Ltd. | Cell culture container and method of producing the same |
JPWO2007097273A1 (en) * | 2006-02-24 | 2009-07-16 | 株式会社クラレ | Resin cell culture container and method for producing the same |
US8435782B2 (en) | 2006-02-24 | 2013-05-07 | Kuraray Co., Ltd. | Cell culture container and method of producing the same |
KR100842378B1 (en) * | 2007-04-27 | 2008-07-01 | 양현진 | Scaffolds increased specific gravity for cell culture and method for manufacturing thereof |
JP2011125232A (en) * | 2009-12-15 | 2011-06-30 | Hoya Corp | Cell culture carrier, and method for producing the same |
WO2017051912A1 (en) * | 2015-09-25 | 2017-03-30 | 三菱瓦斯化学株式会社 | Substrate for cell culture, cell culture method using same, cell culture vessel, and use as substrate |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
De Bartolo et al. | Evaluation of cell behaviour related to physico-chemical properties of polymeric membranes to be used in bioartificial organs | |
CN201193228Y (en) | Three-dimensional cell-culturing insert, manufacturing equipment thereof and kit | |
EP0866849B1 (en) | Solid support for use in cell cultivation, especially for the cultivation of liver cells, biological reactor containing said solid support and the use thereof in a bio-artificial liver system | |
US7541187B2 (en) | Method of providing a substrate with a ready-to-use, uniformly distributed extracellular matrix | |
US20080057578A1 (en) | Process and substrate for culturing cartilage cell, material for reproducing biological tissue containing cartilage cell, and cartilage cell | |
EP0387975A1 (en) | Cell culture substrate cell sheet, cell cluster and preparations thereof | |
JPS63196286A (en) | Base for cell culture | |
JPS63196281A (en) | Substrate for cell culture | |
Gerlach et al. | Comparison of hollow fibre membranes for hepatocyte immobilisation in bioreactors | |
US5702949A (en) | Culture method for multilayer growth of anchorage-dependent cells | |
JPS63198978A (en) | Base material for cultivating cell | |
JP2004057019A (en) | Substrate for cell culture | |
JPS63196280A (en) | Substrate for cell culture | |
JPS63196273A (en) | Substrate for cell culture | |
JPH03266980A (en) | Base material for cell culture and production of cell aggregate using same | |
JPH04237492A (en) | Formed product for culturing cell | |
JPS63196277A (en) | Substrate for cell culture | |
JPS63196285A (en) | Base for cell culture | |
JPS63196272A (en) | Substrate material for cell culture | |
JPS63196274A (en) | Substrate for cell culture | |
JPS63196275A (en) | Substrate for cell culture | |
JPS63198981A (en) | Base material for cultivating cell | |
JPS63196278A (en) | Substrate for cell culture | |
JPS63196279A (en) | Substrate for cell culture | |
JPS63196283A (en) | Base for cell culture |